BridgeMD
New treatment option for Inhibitory Control
Official title Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 2
ClinicalTrials.gov ID: NCT06263712
What this study is testing
- What it's testing
- The present study consists of 3 projects in total and aims to investigate the (neuro-) psychological patterns from suicidal ideation to suicidal behavior as well as the effects and feasibility of ASSIP Home Treatment. The overall aim of project 2 is to investigate how the (neuro-) psychological patterns are modulated by the Attempted Suicide Short Intervention Program (ASSIP).
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- for Project 2: people fulfilling the following are eligible for the study:
- Informed consent as documented by signature
- Age ≥ 18 years
- At least one previous suicide attempt
- Willingness to attend the ASSIP brief therapy
You likely can't join if
- for Project 2: The presence of any one of the following exclusion criteria will lead to exclusion of the subject:
- Serious cognitive impairment
- Any psychotic disorder
- Any current medication, which substantially impairs the attention span, reaction, rate or any other relevant cognitive functions
- Inability to follow the procedures of the study (e.g., insufficient mastery of the German language, previous enrolment into the current study)
See the full eligibility criteria
- for Project 2: people fulfilling the following are eligible for the study:
- Informed consent as documented by signature
- Age ≥ 18 years
- At least one previous suicide attempt
- Willingness to attend the ASSIP brief therapy
- Owns a smartphone
- for Project 2: The presence of any one of the following exclusion criteria will lead to exclusion of the subject:
- Serious cognitive impairment
- Any psychotic disorder
- Any current medication, which substantially impairs the attention span, reaction, rate or any other relevant cognitive functions
- Inability to follow the procedures of the study (e.g., insufficient mastery of the German language, previous enrolment into the current study)
The study team makes the final eligibility decision.
Where it's taking place
- Bern, Switzerland
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bern, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.